Our investigation [58,59] emphasized a correlation between CD146 mRNA detection (from whole peripheral blood) and degree of expression of this marker on the corresponding primary melanoma tissue, tumor thickness, AJCC stages, and clinical outcome. Here, MCAM is linked to neoplasm.